Steve Bobzin built natural products discovery programs for Galileo Pharmaceuticals and Monsanto's Consumer Health and Nutrition sector. There, Dr. Bobzin helped pioneer the application of hybrid analytical technologies, such as LC-MS and LC-NMR, to the identification of natural products from plants and other natural sources. Prior to these endeavors, he spent six years as part of the high-throughput screening team in the pharmaceutical discovery programs of G.D. Searle and Monsanto. Dr. Bobzin holds a Ph.D. in Natural Products Chemistry from Scripps Institution of Oceanography and is an Adjunct Professor at the University of Mississippi School of Pharmacy. |